HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas

BACKGROUND: Gliomas are the most frequent type of central nervous system tumor, accounting for more than 70% of all malignant CNS tumors. Recent research suggests that the hyaluronan-mediated motility receptor (HMMR) could be a novel potential tumor prognostic marker. Furthermore, mounting data has...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Huaxin, Tan, Jiacong, Pan, Xinyi, Ouyang, Hengyang, Zhang, Zhixiong, Li, Meihua, Zhao, Yeyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903609/
https://www.ncbi.nlm.nih.gov/pubmed/36750807
http://dx.doi.org/10.1186/s12885-023-10596-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903609/
https://www.ncbi.nlm.nih.gov/pubmed/36750807
http://dx.doi.org/10.1186/s12885-023-10596-w

Ejemplares similares